Characterization of tau phosphorylation in glycogen synthase kinase-3β and cyclin dependent kinase-5 activator (p23) transfected cells

被引:70
作者
Michel, G [1 ]
Mercken, M [1 ]
Murayama, M [1 ]
Noguchi, K [1 ]
Ishiguro, K [1 ]
Imahori, K [1 ]
Takashima, A [1 ]
机构
[1] Mitsubishi Kasei Inst Life Sci, Machida, Tokyo 194, Japan
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 1998年 / 1380卷 / 02期
关键词
GSK-3; beta; p23; CDK5; tau; phosphorylation site; phosphorylation-dependent anti-tau antibody;
D O I
10.1016/S0304-4165(97)00139-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
One of the histopathological markers in Alzheimer's disease is the accumulation of hyperphosphorylated tau in neurons called neurofibrillary tangles (NFT) composing paired helical filaments (PHF). Combined tau protein kinase II (TPK II), which consists of CDK5 and its activator (p23), and glycogen synthase kinase-3 beta (GSK-3 beta) phosphorylate tau to the PHF-form in vitro. To investigate tau phosphorylation by these kinases in intact cells, the phosphorylation sites were examined in detail using well-characterized phosphorylation-dependent anti-tau antibodies after overexpressing the kinases in COS-7 cells with a human tau isoform. The overexpression of tau in COS-7 cells showed extensive phosphorylation at Ser-202 and Ser-404. The p23 overexpression induced a mobility shift of tau, but most of the phosphorylation sites overlapped the endogenous phosphorylation sites. GSK-3 beta transfection showed the phosphorylation at Ser-199, Thr-231, Ser-396, and Ser-413. Triplicated transfection resulted in phosphorylation of tau at 8 observed sites (Ser-199, Ser-202, Thr-205, Thr-231, Ser-235, Ser-396, Ser-404, and Ser-413). (C) 1998 Elsevier Science B.V.
引用
收藏
页码:177 / 182
页数:6
相关论文
共 32 条
[21]   PROLINE-DIRECTED AND NON-PROLINE-DIRECTED PHOSPHORYLATION OF PHF-TAU [J].
MORISHIMAKAWASHIMA, M ;
HASEGAWA, M ;
TAKIO, K ;
SUZUKI, M ;
YOSHIDA, H ;
TITANI, K ;
IHARA, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (02) :823-829
[22]   RECONSTITUTION OF NEURONAL CDC2-LIKE KINASE FROM BACTERIA-EXPRESSED CDK5 AND AN ACTIVE FRAGMENT OF THE BRAIN-SPECIFIC ACTIVATOR - KINASE ACTIVATION IN THE ABSENCE OF CDK5 PHOSPHORYLATION [J].
QI, Z ;
HUANG, QQ ;
LEE, KY ;
LEW, J ;
WANG, JH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (18) :10847-10854
[23]  
SCOTT CW, 1993, J BIOL CHEM, V268, P1166
[24]   THE MOLECULAR PATHOLOGY OF ALZHEIMERS-DISEASE [J].
SELKOE, DJ .
NEURON, 1991, 6 (04) :487-498
[25]   GLYCOGEN-SYNTHASE KINASE-3-BETA PHOSPHORYLATES TAU-PROTEIN AT MULTIPLE SITES IN INTACT-CELLS [J].
SPERBER, BR ;
LEIGHT, S ;
GOEDERT, M ;
LEE, VMY .
NEUROSCIENCE LETTERS, 1995, 197 (02) :149-153
[26]  
TAKAHASHI M, 1995, J NEUROCHEM, V64, P1759
[27]   P35 IS A NEURAL-SPECIFIC REGULATORY SUBUNIT OF CYCLIN-DEPENDENT KINASE-5 [J].
TSAI, LH ;
DELALLE, I ;
CAVINESS, VS ;
CHAE, T ;
HARLOW, E .
NATURE, 1994, 371 (6496) :419-423
[28]   PRECURSOR OF CDK5 ACTIVATOR, THE 23-KDA SUBUNIT OF TAU-PROTEIN KINASE-II - ITS SEQUENCE AND DEVELOPMENTAL-CHANGE IN BRAIN [J].
UCHIDA, T ;
ISHIGURO, K ;
OHNUMA, J ;
TAKAMATSU, M ;
YONEKURA, S ;
IMAHORI, K .
FEBS LETTERS, 1994, 355 (01) :35-40
[29]  
VULLIET R, 1992, J BIOL CHEM, V267, P22570
[30]  
WATANABE A, 1993, J BIOL CHEM, V268, P25712